Trials / Completed
CompletedNCT01140048
Respiratory Syncytial Virus (RSV) Follow-Up Study (MK-0476-374)
An Observational Follow-Up Study of Pediatric Patients Who Participated in a Previous Respiratory Syncytial Virus (RSV)-Induced Bronchiolitis Study of Montelukast
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 343 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 18 Months – 6 Years
- Healthy volunteers
- Not accepted
Summary
This is a prospective, multicenter, observational study in participants who completed the 24-week, placebo-controlled MK-0476 Protocol 272 (NCT00076973) study of montelukast in the treatment of respiratory symptoms subsequent to RSV-induced bronchiolitis. The purpose of this study is to better understand the clinical and demographic correlates of asthma and atopic disorders in children (through the age of 6 years) with a history of severe RSV-induced bronchiolitis.
Conditions
Timeline
- Start date
- 2007-10-01
- Primary completion
- 2011-10-01
- Completion
- 2011-10-01
- First posted
- 2010-06-09
- Last updated
- 2022-02-02
- Results posted
- 2012-10-05
Source: ClinicalTrials.gov record NCT01140048. Inclusion in this directory is not an endorsement.